CellRep
Founded 2024 · 10 employees on LinkedIn · 2 known investors
Find your way into CellRep
194 people in our graph share verified history with the CellRep team — schools, employers, funds. One of them is your warm intro.
Madison Lenormandunlockedknows Federico Perdomo Celis · together at Institut Pasteur (overlapped)
×4knows the team · via Globant
×3knows the team · via Telefonica
×4knows the team · via Instituto Tecnológico de Buenos Aires
CellRep develops an AI-powered platform that discovers small molecules to reprogram exhausted immune cells, enhancing their function for therapeutic applications including cancer immunotherapy and chronic viral infections. The company's compounds act on multiple biological layers to restore cellular performance without genetic modification.
Founders & leadership
CellRep was founded in 2024 by Alfonso Amat, Federico Perdomo Celis, Manuel Franco Cortés, and Julian Ganzabal.
AA
Alfonso AmatinCEO & Co-FounderAlfonso Amat is CEO and co-founder of CellRep, a company developing an AI-powered platform to discover small molecules that reprogram immune cells for therapeutic applications in cancer immunotherapy and chronic viral infections.
FP
Federico Perdomo CelisinCSO & Co-FounderFederico Perdomo Celis holds an MD and PhD in Immunology, with over a decade of research experience studying T cell responses in chronic viral infections including HIV and hepatitis B, and in cancer. He is Chief Scientific Officer and co-founder of CellRep.
MF
Manuel Franco CortésCCO & Co-Founder
JG
Julian GanzabalinCAIO & Co-FounderJulian Ganzabal is Chief AI Officer and Co-Founder of CellRep, an AI-driven drug discovery platform targeting immune cell reprogramming for cancer and viral therapies. He has worked as a machine learning engineer and teaches deep learning at ITBA.
Investors · 2
Frequently asked questions
- What does CellRep do?
- CellRep develops an AI-powered platform that discovers small molecules to reprogram exhausted immune cells, enhancing their function for therapeutic applications including cancer immunotherapy and chronic viral infections. The company's compounds act on multiple biological layers to restore cellular performance without genetic modification.
- Who founded CellRep?
- CellRep was founded by Alfonso Amat, Federico Perdomo Celis, Manuel Franco Cortés, Julian Ganzabal in 2024.
- Who are CellRep's investors?
- CellRep's investors include AIR Capital, GRIDX.